Spikes on IV administration sets can differ in size/dimensions between different manufacturers. Those with narrow, smaller spikes (for example; BD AlarisTM and Baxter CLEARLINK TM), should be completely inserted, depending on spike set used.Read More
Meropenem is the sixth largest generic anti-infective product in unit volume in hospital and alternate site settings. According to a 2022 IQVIA report, the market value for Meropenem is $88.7 million dollars, with unit volume at 15.9 million annually.Read More
WG Critical Care, LLC is a healthcare company that is dedicated to improving the outcome of patients treated by doctors and other healthcare professionals in critical care facilities throughout the United States. As such, WG Critical Care does not condone the off-label use or misuse of its drugs including the use of its products to...Read More
PARAMUS, UNITED STATES, August 4, 2021 /EINPresswire.com/ — WG Critical Care, LLC will be introducing the first and only FDA-approved, Ready-To-Use (RTU) Midazolam in 0.9% Sodium Chloride Injection CIV in single-dose bags. Midazolam is currently controlled in schedule IV of the Controlled Substance Act. The launch of Ready-To-Use Midazolam in 0.9% Sodium Chloride Injection CIV...Read More
PARAMUS, N.J., Jan. 15, 2019 /PRNewswire/ — WG Critical Care (WGCC), A Pharmasphere company, has launched the first and only FDA approved Calcium Gluconate in Sodium Chloride Injection in a Ready-To-Use Bag. “In addition to addressing a chronic drug shortage of this product, I’m excited to add another unique product to our expanding portfolio,” says...Read More
PARAMUS, N.J., March 1, 2018 /PRNewswire/ — WG Critical Care launched the first and only generic ready-to-use Esmolol HCl in Water for Injection (WFI), 2500 mg/250 mL (10 mg/mL) and Double Strength 2000 mg/100 mL (20 mg/mL). Esmolol is a cardiovascular agent indicated for rapid control of ventricular rate in patients with atrial fibrillation or...Read More
PARAMUS, N.J., Oct. 11, 2016 /PRNewswire/ — (WGCC), a wholly owned subsidiary of PharmaSphere, Inc., announced today that it has launched the first and only 400 mcg/4 mL and 1000 mcg/10 mL multi-dose vials. Dexmedetomidine HCl Injection is currently sold as a 2 mL vial by multiple manufacturers. Dexmedetomidine is also available in ready to...Read More